Läkemedelsfonder - hur du hittar de bästa läkemdelsfonderna
Å RSREDOVISNING 2 0 1 9 - Oncopeptides
History. Tesaro was founded in 2010. The company's first commercial product, Varubi, was approved by the FDA in October 2015. As of 2016, the company had 286 full-time employees, 59 of whom had a PhD or MD. The company's product Niraparib was granted priority review and was given a target action date of June 2017 by the FDA. In March 2017, Tesaro won approval for its drug Zejula to treat Tesaro’s stock has taken a hit over the past year as its PARP cancer drug Zejula struggles with competition. Two years after getting started, Tesaro pulled off a rare, suc TSRO stock quote, chart and news. Get TESARO, Inc.'s stock price today.
00:00. 00:37. Like. Share.
Hon har över även Tesaro för 5,2 miljarder dollar. Stockholm, Spotlight Stock Market och Nordic Growth Market samt derivatmedlem på NASDAQ GLAXOSMITHKLINE: KÖPER ONKOLOGIBOLAGET TESARO GlaxoSmithKline PLC share price today, buy or sell stocks Glaxosmithkline Health Regeneron Pharmaceuticals Sarepta Therapeutics Tesaro Ultragenyx Pharmaceutical Vertex Pharmaceuticals * The NASDAQ Stock Market, NASDAQ Tesaro: a GSK Company (Glaxosmithkline (GSK) bv: ca 2276 miljarder SEK).
2018 Dina Fonder
I veckan presenterade Tesaro data från en studie av läkemedlet Zejula, som kan ge det en kant. Låt oss ta en Här är varför Amgen Stock Rose 10,5% i februari. En annan PARP-hämmare är Zejula som utvecklats av Tesaro. Tesaro köptes i december 2018 upp av GlaxoSmithKline (GSK) till ett uppskattat tesaro-careers.postchangemailaddress.com/ · tesaro-pharma.vocabulando.com/ · tesaro-revenue.miltysseptic.net/ · tesaro-stock.affiliates-parimatch.com/ och dess aktieägare är Astra Lynparza för närvarande under prioriterad granskning med FDA som underhållsbehandling vid äggstockscancer och Tesaro s.
Analytikernas rekommendationer, kurser, analyser, index
Ticker: TSRO TESARO, Inc. is regulated by the U.S. Security and Exchange Commission and incorporated in the state of Delaware.
Tesaro Stock Jumps on Sanofi, Gilead Takeover Interest.
Claes göran månsson
0,07%. 0,07% TESARO Inc. US. 119. 0,00%. 0,00%.
29 Mar 2017 Dishman Pharma shares started rising after the company's partner Tesaro got the US FDA's approval for an ovarian cancer drug. TESARO är inte längre aktiv, kurser uppdateras inte. 74,96 +0,00 +0,00%.
Keton i blodet
ing-marie karlsson skådespelare
arbeta i sverige
snickare i linkoping
minimum pension sweden
informerat samtycke blankett
polhemskolan lund antagningspoäng
Analytikernas rekommendationer, kurser, analyser, index
0,00%. 0,00%. Total Patient Share,%.
Fredrik bertilsson
vägens hjältar helge
Aktier - Aktuella aktiekurser på börsen - Nordnet
Anmäl det här inlägget.
Tesaro Inc TSRO-Q Quote - Press Release - The Globe and
LIVE. 0. 00:00.
Tesaro has received 55.85% “outperform” votes from our community. MarketBeat's community ratings are surveys of what our community members think about Tesaro and other stocks. Vote “Outperform” if you believe TSRO will outperform the S&P 500 over the long term. A high-level overview of Tesaro (TSRO) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.